+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

HIV/AIDS Drugs Market Research Reports

HIV-associated Lipodystrophy - Pipeline Insight, 2025 - Product Thumbnail Image

HIV-associated Lipodystrophy - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Human Immunodeficiency Virus Type 1 (HIV-1) Infection - Pipeline Insight, 2025 - Product Thumbnail Image

Human Immunodeficiency Virus Type 1 (HIV-1) Infection - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 50 Pages
  • Global
From
AIDS Related Kaposi's Sarcoma - Pipeline Insight, 2025 - Product Thumbnail Image

AIDS Related Kaposi's Sarcoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Exportin-1 Protein Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Exportin-1 Protein Inhibitors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
HIV Integrase Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

HIV Integrase Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Integrase Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Integrase Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Fusion Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Fusion Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
HIV-associated Lipodystrophy - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

HIV-associated Lipodystrophy - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • June 2024
  • 200 Pages
  • Global
From
Human Immunodeficiency Virus (HIV 1) Infection Pipeline Analysis Report 2025 - Product Thumbnail Image

Human Immunodeficiency Virus (HIV 1) Infection Pipeline Analysis Report 2025

  • Report
  • June 2025
  • 200 Pages
  • Global
From
Human Immunodeficiency Virus Type 1 Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Thumbnail Image

Human Immunodeficiency Virus Type 1 Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • May 2024
  • 134 Pages
  • Global
From
HIV Treatment Drugs Market in Africa 2024-2028 - Product Thumbnail Image

HIV Treatment Drugs Market in Africa 2024-2028

  • Report
  • July 2024
  • 162 Pages
  • Africa
From
HIV Drugs Market 2024-2028 - Product Thumbnail Image

HIV Drugs Market 2024-2028

  • Report
  • July 2024
  • 164 Pages
  • Global
From
Human Immunodeficiency Virus (HIV) Rapid Test Kits Market Report and Forecast 2024-2032 - Product Thumbnail Image

Human Immunodeficiency Virus (HIV) Rapid Test Kits Market Report and Forecast 2024-2032

  • Report
  • December 2023
  • 221 Pages
  • Global
From
Human Immunodeficiency Virus (HIV): Seven-Market Drug Forecast and Market Analysis - Product Thumbnail Image

Human Immunodeficiency Virus (HIV): Seven-Market Drug Forecast and Market Analysis

  • Report
  • May 2025
  • 134 Pages
  • Global
From
Human Immunodeficiency Virus (HIV): Epidemiology Forecast to 2033 - Product Thumbnail Image

Human Immunodeficiency Virus (HIV): Epidemiology Forecast to 2033

  • Report
  • December 2024
  • 59 Pages
  • Global
From
Asia Pacific HIV Injection Market Size, Share & Trends Analysis Report By Distribution Channel (Hospital Pharmacy, Drugs Stores & Retail Pharmacies, and Others), By Country and Growth Forecast, 2023 - 2030 - Product Thumbnail Image

Asia Pacific HIV Injection Market Size, Share & Trends Analysis Report By Distribution Channel (Hospital Pharmacy, Drugs Stores & Retail Pharmacies, and Others), By Country and Growth Forecast, 2023 - 2030

  • Report
  • March 2024
  • 97 Pages
  • Asia Pacific
From
North America HIV Injection Market Size, Share & Trends Analysis Report By Distribution Channel (Hospital Pharmacy, Drugs Stores & Retail Pharmacies, and Others), By Country and Growth Forecast, 2023 - 2030 - Product Thumbnail Image

North America HIV Injection Market Size, Share & Trends Analysis Report By Distribution Channel (Hospital Pharmacy, Drugs Stores & Retail Pharmacies, and Others), By Country and Growth Forecast, 2023 - 2030

  • Report
  • March 2024
  • 91 Pages
  • North America
From
LAMEA HIV Injection Market Size, Share & Trends Analysis Report By Distribution Channel (Hospital Pharmacy, Drugs Stores & Retail Pharmacies, and Others), By Country and Growth Forecast, 2023 - 2030 - Product Thumbnail Image

LAMEA HIV Injection Market Size, Share & Trends Analysis Report By Distribution Channel (Hospital Pharmacy, Drugs Stores & Retail Pharmacies, and Others), By Country and Growth Forecast, 2023 - 2030

  • Report
  • March 2024
  • 97 Pages
  • Middle East, Africa
From
HIV Injection Market Size, Share & Trends Analysis Report By Distribution Channel (Hospital Pharmacy, Drugs Stores & Retail Pharmacies, and Others), By Regional Outlook and Forecast, 2023 - 2030 - Product Thumbnail Image

HIV Injection Market Size, Share & Trends Analysis Report By Distribution Channel (Hospital Pharmacy, Drugs Stores & Retail Pharmacies, and Others), By Regional Outlook and Forecast, 2023 - 2030

  • Report
  • March 2024
  • 143 Pages
  • Global
From
Europe HIV Injection Market Size, Share & Trends Analysis Report By Distribution Channel (Hospital Pharmacy, Drugs Stores & Retail Pharmacies, and Others), By Country and Growth Forecast, 2023 - 2030 - Product Thumbnail Image

Europe HIV Injection Market Size, Share & Trends Analysis Report By Distribution Channel (Hospital Pharmacy, Drugs Stores & Retail Pharmacies, and Others), By Country and Growth Forecast, 2023 - 2030

  • Report
  • March 2024
  • 95 Pages
  • Europe
From
Loading Indicator

The HIV/AIDS Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat HIV/AIDS. These drugs are used to treat the virus itself, as well as the symptoms and complications associated with it. HIV/AIDS drugs are typically divided into two categories: antiretroviral drugs, which are used to suppress the virus, and prophylactic drugs, which are used to prevent the transmission of the virus. The HIV/AIDS Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Gilead Sciences, Merck, GlaxoSmithKline, Bristol-Myers Squibb, and Pfizer. These companies are constantly developing new drugs and treatments to improve the quality of life for those living with HIV/AIDS. Show Less Read more